Do you want to read an article? Please log in or register.
Biomarkers of risk of switching to dexamethasone implant for the treatment of diabetic macular oedema in real clinical practice: a multicentric study
Macular Diseases
Related content
Macular Diseases
Treatment Regimens with Ranibizumab in Neovascular Age-Related Macular Degeneration: Real-World Results from the PACIFIC Study
Clin Ophthalmol
Lorenz K, Haritoglou C, Barthelmes D, Sefat AMM, Berk H, Beeke E, Scheffler M, Iwersen M, Müller B, Ziemssen F, members of the PACIFIC study group
doi: 10.2147/OPTH.S512630
Glaucoma and Ocular PressureMacular DiseasesRetinal Diseases
Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study
Acta Ophthalmol
Abu Ishkheidem I, Breimer M, Kamal S, Zetterberg M, Al-Hawasi A, Grönlund MA
doi: 10.1111/aos.17475
Macular Diseases
AI-Assisted OCT Clinical Phenotypes of Diabetic Macular Edema: A Large Cohort Clustering Study
J Clin Med
Midena E, Lupidi M, Toto L, Covello G, Veritti D, Pilotto E, Cicinelli MV, Lattanzio R, Figus M, Midena G, Danieli L, Borrelli E, Reibaldi M, Tognetto D, Inferrera L, Donati S, Rossi S, Melillo P, Lanzetta P, Sarao V, Gregori G, Cagini C, Eandi CM, Carnevali A, Scorcia V, Maggio E, Pertile G, Costagliola C, Cennamo G, Mora P, Dell'Omo R, Affatato M, Passamonti M, Parravano M, Lassandro NV, Nassisi M, Viola F, Castellino N, Cappellani F, Giannaccare G, Boscia F, Grassi MO, Musetti D, Folegani V, Invernizzi A, Rossetti L, Bacci T, Ricci F, Lombardo M, Romano M, Valsecchi N, Coppola M, Cavarzeran F, Frizziero L
doi: 10.3390/jcm14227893
Macular Diseases
Real-World Outcomes of Different Types of Treatment for Diabetic Macular Edema Before and After Approval of Anti-Vascular Endothelium Growth Factor Agents
J Clin Med
Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, Terasaki H, Kondo M, Writing Committee Of Japan-Clinical Retina Study Group J-Crest
doi: 10.3390/jcm13237336
Macular DiseasesRetinal Diseases
Visual outcomes and anatomical biomarkers of Faricimab for diabetic macular edema in the J-CREST real-world comparison of naïve and treated eyes
Sci Rep
Murao F, Yanai R, Kusuhara S, Abe Y, Shimura M, Ohara H, Terasaki H, Sugimoto M, Matsubara H, Hirano Y, Kinoshita T, Tsujinaka H, Seki K, Iwase T, Mitamura Y, J-CREST
doi: 10.1038/s41598-025-20300-6
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular Diseases
Differentiating treatment episodes from gaps in eyes with diabetic macular oedema
Br J Ophthalmol
Hashimoto Y, Hunt AR, Silva R, Witmer A, Kheir WJ, Viola F, Arrazola M, Mahgoub MM, Pollreisz A, Harvey Z, Barthelmes D, Gillies MC
doi: 10.1136/bjo-2025-327238
Macular Diseases
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial
JAMA Ophthalmol
Khanani AM, Campochiaro PA, Graff JM, Marcus DM, Miller D, Mittra RA, Regillo C, Sheth VS, Bobbala A, Gune S, Lin S, Quezada-Ruiz C, Malhotra V
doi: 10.1001/jamaophthalmol.2025.0006
Macular Diseases
Adherence to Anti-VEGF Treatment in Patients with Neovascular Age-Related Macular Degeneration: A Real-World Study
Ophthalmol Ther
Shellvarajah M, Nguyen V, Steinmann S, Gillies MC, Sagkriotis A, Barthelmes D
doi: 10.1007/s40123-025-01140-z